New Weight Management Treatment Approved for Obese Adults
A new injectable treatment for weight management, Wegovy, has been approved for use in adult patients with obesity in the UK. Administered as a series of injections, the drug is designed to be used alongside a reduced-calorie diet and exercise for those with a Body Mass Index (BMI) of 30kg/m² or greater.
Prescription Guidelines
This treatment is exclusively for individuals classified as obese, and it is not indicated for overweight patients who have a BMI below 30kg/m². Additionally, Wegovy is not intended for those looking to lower their risk of heart-related health problems.
Dosage and Administration
The protocol for administering Wegovy involves a gradual increase in dosage starting with an initial weekly dose of 0.25mg. Patients will be guided by their prescribing healthcare professional to elevate their dose every four weeks until they reach the therapeutic dose of 2.4mg per week. If necessary, patients can escalate their dosage to a maximum of 7.2mg per week—achieved through three consecutive 2.4mg injections on the same day.
Injection Protocol
Patients using the 7.2mg dosing regimen should ensure that injections are given in the same anatomical area but spaced at least 5cm apart. It is critical to switch needles between doses and to use multiple pens if needed. Each pen contains up to four doses of 2.4mg, which must be retained until the last dose is administered. Any remaining pens should be stored in a refrigerator with the needle removed, and should only be discarded once all doses have been used, following proper disposal guidance from a healthcare provider.
Monitoring and Reporting Side Effects
Patients are encouraged to engage in open discussions with their healthcare providers regarding any side effects they may experience while using Wegovy. Additionally, they can report these side effects through the MHRA Yellow Card scheme, which is accessible online or via mobile apps.
Background
The advent of Wegovy represents a significant development in obesity management, a growing health concern in the UK and worldwide. With rising rates of obesity linked to various health complications, new and effective treatment options are being sought to assist patients in achieving sustainable weight loss.
Source: official statements, news agencies, and public reports.
https://www.gov.uk/government/news/medicines-regulator-approves-up-to-72mg-dose-of-semaglutidewegovy-for-patients-with-obesity-only
